Skip to main content

Table 2 Provider anti-malarial treatment knowledge by outlet type

From: The malaria testing and treatment landscape in the southern Lao People’s Democratic Republic (PDR)

 

Public health facility

Community health worker

Public sector total

Private for-profit facility

Pharmacy

General retailer

Private sector total

 

%

(95% CI)

%

(95% CI)

%

(95% CI)

%

(95% CI)

%

(95% CI)

%

(95% CI)

%

(95% CI)

Proportion of providers who:

N = 91

N = 164

N = 255

N = 58

N = 327

N = 30

N = 424

Correctly state the national first-line treatment for uncomplicated P. falciparum/vivax malaria, AL

89.5

(81.7, 94.2)

72.6

(64.7, 79.3)

77.9

(72.0, 82.9)

78.7

(63.8, 88.5)

49.5

(39.0, 60.0)

8.1

(2.7, 21.9)

40.4

(31.6, 49.8)

Correctly state the first-line (AL) dosing regimen for uncomplicated P. falciparum/vivax malaria for an adult

73.0

(60.7, 82.5)

51.3

(41.0, 61.5)

58.2

(49.6, 66.3)

66.4

(51.1, 78.8)

36.5

(28.0, 46.0)

6.1

(1.6, 20.6)

30.2

(23.1, 38.2)

  1. AL artemether–lumefantrine